Загрузка...
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC) has been made over the past decade, the 5-year survival rate in patients with lung cancer remains only...
Сохранить в:
| Опубликовано в: : | Tuberc Respir Dis (Seoul) |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771744/ https://ncbi.nlm.nih.gov/pubmed/29332322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2017.0120 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|